FDA announces plans to pilot end-stage kidney disease technology in new program
Innovation Pathway aims to reduce time and cost of bringing safe and effective, breakthrough technologies to patients.
Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA’s Innovation Pathway, an evolving system designed to help medical devices reach patients in
Subscribe to:
Post Comments (Atom)
Post a Comment